Literature DB >> 21944169

Decreased plasma brain-derived neurotrophic factor levels in institutionalized elderly with depressive disorder.

Chin-Liang Chu1, Chih-Kuang Liang, Ming-Yueh Chou, Yu-Te Lin, Chih-Chuan Pan, Ti Lu, Liang-Kung Chen, Philip C Chow.   

Abstract

OBJECTIVES: To compare the differences in plasma brain-derived neurotrophic factor (BDNF) levels among institutionalized ethnic Chinese elderly participants with major depression, those with subclinical depression, and a nondepressed control group.
DESIGN: A cross-sectional study.
SETTING: The veterans' home in southern Taiwan. PARTICIPANTS: One hundred sixty-seven residents. MEASUREMENTS: Questionnaires including the Minimum Data Set Nursing Home 2.1, Chinese-language version, and the short-form Geriatric Depression Scale, Chinese-language version. Depressive disorder was diagnosed by a well-trained psychiatrist using DSM-IV-TR (Diagnostic and Statistical Manual of Mental Disorders, 4th edition, text revision) criteria. We measured plasma BDNF levels in the following 3 groups: nondepressive subjects (n = 122), subclinically depressive subjects (n = 33), and subjects with major depression (n = 12). Plasma BDNF was assayed using the sandwich ELISA method.
RESULTS: We noted a significantly negative association between age and plasma BDNF in the regression model. There was no significant correlation between BDNF plasma levels and body weight or platelet counts. We found that plasma BDNF was significantly lower in the major depressive group (mean, 115.1 pg/mL; SD, 57.2) than in the nondepressive group (mean, 548.8 pg/mL; SD, 370.6; P < .001). The BDNF plasma concentrations in the subclinically depressive group (mean, 231.8 pg/mL; SD, 92.4; P < .001) and control group were also significantly different.
CONCLUSIONS: Our findings revealed that plasma BDNF levels were reduced not only in ethnic Chinese elderly patients with major depressive disorder but also in those with subclinical depression. This makes the plasma BDNF level a potential biological marker for clinical or subclinical depression.
Copyright © 2012 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21944169     DOI: 10.1016/j.jamda.2011.08.006

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  8 in total

1.  Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.

Authors:  Antón Alvarez; Manuel Aleixandre; Carlos Linares; Eliezer Masliah; Herbert Moessler
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 2.  Involvement of brain-derived neurotrophic factor in late-life depression.

Authors:  Yogesh Dwivedi
Journal:  Am J Geriatr Psychiatry       Date:  2013-03-19       Impact factor: 4.105

3.  Association of peripheral manifestation of brain-derived neurotrophic factor with depression: A meta-analysis.

Authors:  Sagun Tiwari; Lili Qi; John Wong; Zhenxiang Han
Journal:  Brain Behav       Date:  2022-05-05       Impact factor: 3.405

4.  Risk of Vertebral Fracture in Patients Diagnosed with a Depressive Disorder: A Nationwide Population-Based Cohort Study.

Authors:  Shyh-Chyang Lee; Li-Yu Hu; Min-Wei Huang; Cheng-Che Shen; Wei-Lun Huang; Ti Lu; Chiao-Lin Hsu; Chih-Chuan Pan
Journal:  Clinics (Sao Paulo)       Date:  2017-01-01       Impact factor: 2.365

5.  Serum BDNF Levels are Not Associated with the Antidepressant Effects of Nonconvulsive Electrotherapy.

Authors:  Wei Zheng; Miao-Ling Jiang; Hong-Bo He; Ri-Peng Li; Qi-Long Li; Chun-Ping Zhang; Su-Miao Zhou; Su Yan; Yu-Ping Ning; Xiong Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-06-22       Impact factor: 2.570

Review 6.  Blood Brain-Derived Neurotrophic Factor (BDNF) and Major Depression: Do We Have a Translational Perspective?

Authors:  Beatrice Arosio; Franca Rosa Guerini; Richard C Oude Voshaar; Ivan Aprahamian
Journal:  Front Behav Neurosci       Date:  2021-02-12       Impact factor: 3.558

Review 7.  Neurotrophins as Therapeutic Agents for Parkinson's Disease; New Chances From Focused Ultrasound?

Authors:  Alessandro Stefani; Mariangela Pierantozzi; Silvia Cardarelli; Lucrezia Stefani; Rocco Cerroni; Matteo Conti; Elena Garasto; Nicola B Mercuri; Carmine Marini; Patrizia Sucapane
Journal:  Front Neurosci       Date:  2022-03-25       Impact factor: 4.677

8.  Reduced serum BDNF levels are associated with the increased risk for developing MDD: a case-control study with or without antidepressant therapy.

Authors:  Md Prova Zaman Emon; Rajesh Das; Nuruna Lovely Nishuty; M M A Shalahuddin Qusar; Mohiuddin Ahmed Bhuiyan; Md Rabiul Islam
Journal:  BMC Res Notes       Date:  2020-02-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.